How stress hormone receptors shape PTSD risk and symptoms
Official title: Glucocorticoid Receptor Mechanisms of Traumatic Stress Pathology
Funded at Cincinnati VA Medical Center Research · NIH-11131056 · Data updated 2026-11-12
This work looks at how stress hormones and their receptor systems can make some people more likely to develop lasting fear, anxiety, and memory problems after trauma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati VA Medical Center Research NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | August 1, 2022 |
| Project end | July 31, 2026 |
| Funding year | 2025 |
| NIH project number | 5I01BX005923-04 |
| Project ID | NIH-11131056 on NIH RePORTER |
Who could benefit from this research
✓Could help
The findings would be most relevant to people with PTSD or those at high risk after trauma exposure, including many military veterans and survivors of sexual assault.
✕Less likely to help
Because this is primarily laboratory and animal-based work, people seeking an immediate clinical treatment are unlikely to gain direct benefit from participating.
What this research studies
From a patient's point of view, the team is trying to understand why some people develop PTSD after trauma by studying how stress hormones and their receptors change brain circuits that control fear and emotion. They focus on glucocorticoid receptors and the regulatory protein FKBP5, using lab models that reproduce stress-related hormone changes seen in people with PTSD. Experiments examine connections between the prefrontal cortex and amygdala, and they use genetic and hormone-manipulation approaches to see how these changes drive behavior. The goal is to link gene and hormone differences to the kinds of fear, anxiety, and memory problems patients experience after trauma.
Why it matters
Potential benefit: If successful, this research could point to new targets for drugs or hormone-based treatments to reduce PTSD symptoms or lower risk after trauma.
How similar studies have gone: Prior human genetic and animal studies have linked glucocorticoid receptor signaling and FKBP5 to PTSD, but translating those findings into new patient treatments remains early-stage.
Where this research is happening
-
Cincinnati VA Medical Center Research
Cincinnati, United States Active
Researchers
- Principal investigator: Herman, James P — Cincinnati VA Medical Center Research
- Study coordinator: Herman, James P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.